Payment obligation

 Information for the Manufacturers, for the Marketing Authorisation Holders and for the Wholesalers

- According to the Chapter V. of Act XCVIII of 2006. On the general rules of safe and economic medicine and medical device provision and the distribution of medicinal products (Furthermore: Act) there is a payment obligation. Article 37 of the Act states that the responsible body for the Health Insurance Fund’s management (National Health Insurance Fund Administration, furthermore OEP) has to provide necessary information about the turnover and the reimbursement for the fulfilment of the self-assessment payment obligations. OEP aims to determine transparent and unambiguous payment obligations, so It publishes extra information on its official homepage to help the involved companies. The published turnover and reimbursement data are coming from the OEP’s informatics database, beyond that all provided data are derived from the database therefore informative. The different calculations are based on the OEP’s law interpretation. During the control of the national tax authority (NAV) the stated data can differ from OEP’s calculation. OEP provides this information to help the stakeholders complying with the Act.

 The information about the payment obligation and the statements can be found here:

 

Statements of the year 2017 »

Statements of the year 2016 »

Statements of the year 2015 »

Statements of the year 2014 »

Statements of the year 2013 »

Statements of the year 2012 »

Statements of the year 2011 »

Statements of the year 2010 »

Statements of the year 2009 »

Statements of the year 2008 »

Statements of the year 2007 »